Cognition Therapeutics, Inc. (CGTX) vs Cardiff Oncology, Inc. (CRDF)
A side-by-side comparison of Cognition Therapeutics, Inc. and Cardiff Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGTX
Cognition Therapeutics, Inc.
$0.94HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CRDF
Cardiff Oncology, Inc.
$1.15HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — CGTX vs CRDF
growth of $100 · dividends reinvested · last 5yCGTX -92.7% (-40.7%/yr)CRDF -82.6% (-29.6%/yr)CRDF compounded faster over this window
CGTX CRDF
CGTX vs CRDF: by the numbers
- •CRDF is the larger company ($89M vs $84M market cap).
- •Both run net losses; CGTX's is the smaller (0.00% vs -7884.06% net margin).
Metrics side by side
Valuation
| Metric | CGTX | CRDF |
|---|---|---|
| P/S ratio | N/A | 174.48 |
| P/B ratio | 2.55 | 3.34 |
Profitability
| Metric | CGTX | CRDF |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -8256.32% |
| Net margin | 0.00% | -7884.06% |
| ROE | -50.80% | -150.95% |
| ROIC | -109.43% | -159.30% |
Growth (annualized)
| Metric | CGTX | CRDF |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.15% |
| Total return CAGR (5Y) | N/A | -30.36% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.